SCHEMBL18875249

SCHEMBL18875249

c1ccc2c(c1)Sc1ccccc1N2c1cc(-c2cc(-c3nc4ccccc4o3)cc(N3c4ccccc4Sc4ccccc43)c2)cc(-c2nc3ccccc3o2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 8/20 0.48
KDM4E B2RXH2 8/20 0.48
ALDH1A1 P00352 7/20 0.48
HPGD P15428 7/20 0.48
HSD17B10 Q99714 5/20 0.48
TP53 P04637 5/20 0.48
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
PKM P14618 1/20 0.48
NPC1 O15118 9/20 0.45
RAB9A P51151 7/20 0.45
ATM Q13315 1/20 0.43
LMNA P02545 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
MAPT P10636 2/20 0.41
NFKB1 P19838 2/20 0.41
STAT1 P42224 2/20 0.41
NFKB2 Q00653 2/20 0.41
RELA Q04206 2/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18875208 0.99 SMN1; SMN2 (0.49) SMN1; SMN2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL18875255 0.93 SMN1; SMN2 (0.43) SMN1; SMN2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL18875222 0.88 TP53 (0.43) SMN1; SMN2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL17038492 0.87 NPC1 (0.60) SMN1; SMN2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL18875308 0.85 KDM4E (0.41) SMN1; SMN2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL18875267 0.85 NPC1 (0.43) SMN1; SMN2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL18875219 0.84 TP53 (0.39) SMN1; SMN2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL18875223 0.84 TP53 (0.39) SMN1; SMN2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL18875254 0.84 ALDH1A1 (0.47) SMN1; SMN2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL18875136 0.83 SMN1; SMN2 (0.49) SMN1; SMN2KDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170148996-A1 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC OPTOELECTRONIC DEVICES COMPRISING THE SAME WUHAN TIANMA MICROELECTRONICS CO., LTD.SHANGHAI BRANCH (CN) 2017-05-25 US disclosed
US-20170148996-A1 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC OPTOELECTRONIC DEVICES COMPRISING THE SAME WUHAN TIANMA MICROELECTRONICS CO., LTD.SHANGHAI BRANCH (CN) 2017-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170148996-A1 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC OPTOELECTRONIC DEVICES COMPRISING THE SAME OR10J3, PPOX, OR51E2 SMN1; SMN2 4625/4885KDM4E 2416/4885ALDH1A1 625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.